RxDoctor Payments Data

Frederick Burford, DO

Family Medicine · Fort Myers, FLNPI 1033226329

Payments from drug & device makers

$9,000in general payments, 2019–2025

Across 526 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AbbVie$887
  • Amgen$675
  • AstraZeneca$618
  • Lilly USA, LLC$567
  • Novo Nordisk$561
  • plus $5K from 47 others

What the payments were for

  • Food & beverage$8,75797%
  • Education$1231%
  • Gifts$1191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,000 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$207,367
Medicare patients
344
Services billed
5,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin113$156,954
EliquisApixaban132$124,839
FarxigaDapagliflozin Propanediol111$119,223
OzempicSemaglutide81$106,860
XareltoRivaroxaban39$36,348
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$35,580
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog33$33,897
JanuviaSitagliptin Phosphate26$33,641
MounjaroTirzepatide30$31,255
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df12$29,187
TrulicityDulaglutide12$20,052
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$17,003
LinzessLinaclotide21$15,202
Soliqua 100-33Insulin Glargine/Lixisenatide19$14,389
Emgality PenGalcanezumab-Gnlm14$13,484

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$37$156,954113 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$618$131,705139 claims
PfizerEliquis$493$124,839132 claims
Novo NordiskOzempic$561$106,86081 claims
Lilly USA, LLCMounjaro, Trulicity$567$51,30742 claims
Johnson & JohnsonXarelto$146$36,34839 claims
GSKTrelegy Ellipta$1,066$35,58034 claims
MerckJanuvia$163$33,64126 claims
AbbVieLinzess, Synthroid$887$17,23954 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$86$14,38919 claims
Astellas Pharma US IncMyrbetriq$46$9,64011 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$275$5,59212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →